Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 19.1713.5429.1926.12-1.19

What is the latest EV/Core EBITDA ratio of GLAND PHARMA ?

The latest EV/Core EBITDA ratio of GLAND PHARMA is 19.17 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.17
Mar202313.54
Mar202229.19
Mar202126.12
Mar2020-1.19

How is EV/Core EBITDA of GLAND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 19.17
41.58
Mar2023 13.54
-53.61
Mar2022 29.19
11.75
Mar2021 26.12
Positive
Mar2020 -1.19 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Core EBITDA ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹33,092.7 Cr 8% 15.8% -1.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,667.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹180,131.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,745.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,603.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,429.0 Cr 0.7% -3.8% -7.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

8%

15.8%

-1.5%

SENSEX

-1.1%

0.8%

2.2%


You may also like the below Video Courses